Joshi Venugopal

General Manager and Head of Europe, Novartis Gene Therapies & Rare Diseases • Novartis Gene Therapies

Joshi Venugopal is the Head of Europe for Novartis Gene Therapies and this role involves full P&L and people responsibility for the rare disease stand-alone business unit in Europe with annual sales of over 1.2 billion USD. Before this, Joshi was Commercial Head for all Phase 2, Phase 1 and pre-clinical projects across all therapeutic areas in Novartis Pharma with an estimated pipeline value (risk-adjusted NPV) of over 60 billion USD. Joshi led Project Libra which helped the company make the strategic pivot to focus on US blockbusters and fewer therapeutic areas.

Also speaking

Stuart Curbishley

Chief Manufacturing and Development Officer • Adthera Bio

Marc Davies

Vice President of R&D • Leucid Bio

Stephen Sullivan

Chief Operating Officer • iPSirius

Event Info


Event Brochure

Take a look at the 2023 Event Brochure for Advanced Therapies Europe.

Download the 2023 Speaker List

Download the 2023 Speaker List for Advanced Therapies Europe here.